Linagent-M (2.5/1000) combines Linagliptin (2.5 mg) and Metformin Hydrochloride (1000 mg) for effective management of blood glucose levels in adults with type 2 diabetes. Linagliptin a DPP-4 inhibitor enhances incretin levels to stimulate insulin secretion and decrease glucagon release. Metformin works by reducing hepatic glucose production and improving insulin sensitivity in peripheral tissues. This powerful combination not only helps achieve glycemic control but also supports weight management making it a comprehensive choice for diabetes care.
Reviews
There are no reviews yet.